                         SEQUENCE LISTING

<110>  Max Biopharma Inc.
       Japan As Represented by Director-General of Nation 
       Institute of Infectious Diseases
 
<120>  METHODS AND COMPOSITIONS FOR TREATING VIRAL INFECTIONS

<130>  088907-000001WO00

<140>  PCT/US21/54049
<141>  2021-10-07

<150>  63/089,288
<151>  2020-10-08

<160>  9     

<170>  PatentIn version 3.5

<210>  1
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  1
aaggtaggag ctggagcatt cg                                                22


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  2
aggcggattt gctggcaaag                                                   20


<210>  3
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  3
agccctcagg ctcagggcat ac                                                22


<210>  4
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  4
cgtctgtgcc ttctcatctg c                                                 21


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  5
gcacagcttg gaggcttgaa                                                   20


<210>  6
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  6
ctgtaggcat aaattggt                                                     18


<210>  7
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  7
acaggtacgt taatagttaa tagcgt                                            26


<210>  8
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  8
atattgcagc agtacgcaca ca                                                22


<210>  9
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: Synthetic oligonucleotide

<400>  9
acactagcca tccttactgc gcttcg                                            26
